Magnolia Steripath Blood Collection System

Training and education have long been the standard intervention, but they only show modest, unsustainable reductions in contamination rates because they cannot address potential contaminants that are viable in the keratin layer of the skin even after skin prep. Manual diversion methods to remove contaminants prior to specimen collection are impractical for busy departments and difficult to sustain and reproduce results. Passive diversion options create the potential for the contaminated blood to mix with the culture specimen, are susceptible to bypassing diversion, and do not conform to published guidelines on clinically proven diversion volumes.

Steripath prevents contaminants from entering the blood culture bottle by utilizing engineered compliance that will not allow specimen collection until diversion is complete, providing a sustained contamination rate as low as 0.0%

Magnolia Medical Technologies is a pioneering company specializing in innovative solutions for diagnostic accuracy in blood culture collection. Their flagship technology, Steripath®, is designed to reduce blood culture contamination, ensuring more reliable test results and improving patient care. By addressing contamination at the source, Magnolia Medical helps healthcare providers make more accurate diagnoses, optimize antibiotic use, and reduce unnecessary treatments. Committed to enhancing clinical outcomes and patient safety, Magnolia Medical is at the forefront of transforming diagnostic practices in healthcare.